Managing quality vs. measuring uncertainty in the medical laboratory
-
James O. Westgard
Abstract
ISO 15189's particular requirements for quality management in medical laboratories provide guidance for (a) relating performance specifications to the intended use of a test or examination procedure, (b) designing internal quality control (IQC) procedures to verify the attainment of the intended quality of test results, as well as (c) determining the uncertainty or results, where relevant and possible. This guidance has particular implications for analytical quality management, specifically for validating method performance relative to quality goals or requirements (intended use), designing statistical quality control procedures on the basis of the quality required for a test and the precision and bias observed for a method, and characterizing the quality achieved in practice by calculating measurement uncertainty. There already exists an error framework that provides practical tools and guidance for managing analytical quality, along with an existing concept of total error that can be used to characterize the quality of laboratory tests, thus there is considerable concern and debate on the merits and usefulness of measurement uncertainty. This paper argues that total error provides a practical top-down estimate of measurement uncertainty in the laboratory, and that the ISO/GUM model should be primarily directed to and applied by manufacturers.
Clin Chem Lab Med 2010;48:31–40.
©2010 by Walter de Gruyter Berlin New York
Articles in the same Issue
- Editorials
- Rapid diagnosis of swine-origin influenza A (H1N1) virus (S-OIV): useful or hype?
- Application of traceability concepts to analytical quality control may reconcile total error with uncertainty of measurement
- Reviews
- Pandemic influenza A (H1N1) 2009: the experience of the first six months
- The role of anti-core antibody response in the detection of occult hepatitis B virus infection
- Opinion Papers
- Managing quality vs. measuring uncertainty in the medical laboratory
- Collective opinion paper on findings of the 2009 convocation of experts on quality control
- General Clinical Chemistry and Laboratory Medicine
- Diagnostic performance of rapid influenza antigen assays in patients infected with the new influenza A (H1N1) virus
- Achieving continuous improvement in laboratory organization through performance measurements: a seven-year experience
- Evaluation of errors in a clinical laboratory: a one-year experience
- Validation and Outcome Studies
- Analytical validation of serum bone alkaline phosphatase (BAP OSTASE) on Liaison
- Analytical performance of the serum free light chain assay
- A study on the stability of urinary free catecholamines and free methyl-derivatives at different pH, temperature and time of storage
- Plasma nitrite/nitrate concentrations in patients with schizophrenia
- Inverse relationship between serum high density lipoprotein and negative syndrome in antipsychotic-naive schizophrenia
- Reference Values and Biological Variations
- Biological variation of free plasma amino acids in healthy individuals
- Differences in serum potassium concentrations between Chinese, Indians and Malays
- Determination of median levels of the free β subunit of human chorionic gonadotropin in women from mainland China using a new time-resolved fluoroimmunoassay
- Age- and gender-specific reference ranges for serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 concentrations on the Immulite 2500: results of the Study of Health in Pomerania (SHIP)
- Cardiovascular Diseases
- Improvement of the cardiac marker N-terminal-pro brain natriuretic peptide through adjustment for renal function: a stratified multicenter trial
- Plasma homocysteine, apolipoprotein E status and vascular disease in elderly patients with mental illness
- Letters to the Editor
- Serum total and free sialic acid in patients with chronic liver disease
- Measurement of nitrotyrosine in plasma by immunoassays is fraught with danger: commercial availability is no guarantee of analytical reliability
- Problems with the determination of nitrotyrosine in human plasma are not solved in a satisfactory way and conclusions from clinical trials need to be carefully revised
Articles in the same Issue
- Editorials
- Rapid diagnosis of swine-origin influenza A (H1N1) virus (S-OIV): useful or hype?
- Application of traceability concepts to analytical quality control may reconcile total error with uncertainty of measurement
- Reviews
- Pandemic influenza A (H1N1) 2009: the experience of the first six months
- The role of anti-core antibody response in the detection of occult hepatitis B virus infection
- Opinion Papers
- Managing quality vs. measuring uncertainty in the medical laboratory
- Collective opinion paper on findings of the 2009 convocation of experts on quality control
- General Clinical Chemistry and Laboratory Medicine
- Diagnostic performance of rapid influenza antigen assays in patients infected with the new influenza A (H1N1) virus
- Achieving continuous improvement in laboratory organization through performance measurements: a seven-year experience
- Evaluation of errors in a clinical laboratory: a one-year experience
- Validation and Outcome Studies
- Analytical validation of serum bone alkaline phosphatase (BAP OSTASE) on Liaison
- Analytical performance of the serum free light chain assay
- A study on the stability of urinary free catecholamines and free methyl-derivatives at different pH, temperature and time of storage
- Plasma nitrite/nitrate concentrations in patients with schizophrenia
- Inverse relationship between serum high density lipoprotein and negative syndrome in antipsychotic-naive schizophrenia
- Reference Values and Biological Variations
- Biological variation of free plasma amino acids in healthy individuals
- Differences in serum potassium concentrations between Chinese, Indians and Malays
- Determination of median levels of the free β subunit of human chorionic gonadotropin in women from mainland China using a new time-resolved fluoroimmunoassay
- Age- and gender-specific reference ranges for serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 concentrations on the Immulite 2500: results of the Study of Health in Pomerania (SHIP)
- Cardiovascular Diseases
- Improvement of the cardiac marker N-terminal-pro brain natriuretic peptide through adjustment for renal function: a stratified multicenter trial
- Plasma homocysteine, apolipoprotein E status and vascular disease in elderly patients with mental illness
- Letters to the Editor
- Serum total and free sialic acid in patients with chronic liver disease
- Measurement of nitrotyrosine in plasma by immunoassays is fraught with danger: commercial availability is no guarantee of analytical reliability
- Problems with the determination of nitrotyrosine in human plasma are not solved in a satisfactory way and conclusions from clinical trials need to be carefully revised